Cosmos Holdings competitors

Cosmos Holdings Competitors include Vitality Biopharma, Opiant Pharmaceuticals, IntelGenx and E-Therapeutics.
Add company...
Cosmos Holdings
Cosmos Holdings
Cosmos Holdings is a fully reporting Pharmaceutical Holding Company based in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe.
Vitality Biopharma
Vitality Biopharma
Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
IntelGenx
IntelGenx
IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
E-Therapeutics
E-Therapeutics
e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.
Founding Date
Founding Date
N/A
Founding Date
2012
Founding Date
2009
Founding Date
2003
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Chicago, US HQ
Locations
Los Angeles, US HQ
Locations
Santa Monica, US HQ
Locations
Saint-Laurent, CA HQ
Locations
Long Hanborough, GB HQ
Employees
Employees
1
Employees
7
Employees
3
Employees
12
Employees
2411% decrease
Valuation ($)
Valuation ($)
75 m
Valuation ($)
38.8 m
Valuation ($)
58.5 m
Valuation ($)
50.1 m
Valuation ($)
36.1 m

Financial

Revenue (est.)
Revenue (est.)
$30m (FY, 2017)
Revenue (est.)
$102.4k (FY, 2018)
Revenue (est.)
$18.4m (FY, 2017)
Revenue (est.)
$5.2m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$28.1m (FY, 2017)
Cost of goods
$77.9k (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$2m (FY, 2017)
Gross profit
$24.5k (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($6.2m) (FY, 2017)
Net income
($4.3m) (FY, 2018)
Net income
$6.6m (FY, 2017)
Net income
($3.1m) (FY, 2017)
Net income
(£5.4m) (FY, 2018)
For sources of this data, please see the company profileDownload Excel

View company profiles

Vitality Biopharma
HQ
Los Angeles, US
Employees
7

Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions.

View company
Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
3

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company
IntelGenx
HQ
Saint-Laurent, CA
Employees
12

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.

View company
E-Therapeutics
HQ
Long Hanborough, GB
Employees
24↓ 11% decrease

e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.

View company